(Q34564920)

3 August 2017

1 reference

title

Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure (English)

1 reference

3 August 2017

2

Paul M Ness

1 reference

3 August 2017

Michael B Streiff

1

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

42

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

18-26

1 reference

A Specific Inhibitor of Human Clotting Factor V

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Factor V anticoagulants: clinical, biochemical, and immunological observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Factor V Inhibitor: Report of a Case, with Comments on a Possible Effect of Streptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Observations on a Factor-V Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

A circulating anticoagulant against factor V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Isolation and study of an acquired inhibitor of human coagulation factor V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Factor V inhibitor and bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Fibrin glue: the perfect operative sealant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Development of anti-bovine thrombin antibodies following neurosurgical procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

A case of factor V inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00011.X

10.1046/J.1537-2995.2002.00011.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference